A genetic approach to diagnosis, risk assessment and personalized treatment
Cancer genetics is a field of molecular genetics dedicated to studying the genetic changes involved in cancer development. Genetic testing now plays a major role in cancer diagnosis, treatment planning and disease monitoring.
All cancers arise from genetic changes, but not all cancers are inherited. Some changes are passed down through families, while others develop during a person's lifetime. Cancer genetic testing helps distinguish between these situations and supports sound clinical decision-making.
Why Is Cancer Genetic Testing Performed?
Cancer genetic analyses can help:
1
2
3
4
These tests are valuable not only for a current condition but also for preventive healthcare planning for the future.
HereditaryCancerGeneticTesting
Assessing familial risk
Hereditary cancer testing looks for genetic changes present from birth that may increase a person's cancer risk. It provides particularly important information for risk assessment and early preventive action in people with a family history of cancer.
SomaticTumorGeneticTesting
Examining the genetic profile of a tumor
Somatic testing is performed on genetic material obtained directly from tumor tissue or blood.
These analyses can:
define the tumor's genetic profile.
support the assessment of targeted therapies and immunotherapy options.
monitor response to treatment.
This approach forms the basis of personalized treatment planning.
LiquidBiopsy
Advanced tumor analysis from a blood sample
A liquid biopsy makes it possible to analyze tumor-related genetic changes using a simple blood sample.
Advantages of this method include:
a minimally invasive procedure
the ability to repeat testing during treatment
close monitoring of disease progression
Cancer genetic testing supports more than diagnosis: it also enables early preventive action, appropriate treatment and informed follow-up for the individual and their family.
